Corrigendum to ‘A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours’ [Eur J Cancer 104 (November 2018) 1–8]
Titel:
Corrigendum to ‘A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours’ [Eur J Cancer 104 (November 2018) 1–8]
Auteur:
Gazzah, Anas Boni, Valentina Soria, Jean-Charles Calles, Antonio Even, Caroline Doger, Bernard Mahjoubi, Linda Bahleda, Rastislav Ould-Kaci, Mahmoud Esler, Anne Nazabadioko, Serge Calvo, Emiliano